Ebolavirus interferon antagonists-protein interaction perspectives to combat pathogenesis.

Area of Science:

• Virology
• Immunology
• Computational Biology

Background:

• Zaire ebolavirus is a highly infectious and lethal pathogen.
• Viral proteins (VPs) like VP24 and VP35 antagonize human interferon (IFN) response.
• Limited knowledge of VP binding sites hinders vaccine and drug development.

Purpose of the Study:

• To elaborate on viral and human IFN protein interactions causing viral antagonism.
• To propose a computational framework for identifying critical VP-human protein interaction sites.
• To investigate VP24 interactions with human KPNA5.

Main Methods:

• Evaluation of existing computational studies on viral protein interactions.
• Development of a protein interaction and protein design-based computational framework.
• Identification of critical interacting residues in VP24 using the proposed framework.

Main Results:

• The computational framework identified specific VP24 residues critical for stable complex formation with human KPNA5.
• Mutating these identified residues significantly decreased complex stability.
• A sharp reduction in hydrogen bonds and charge-charge interactions was observed upon mutation.

Conclusions:

• The proposed computational framework is an effective alternative to experimental methods for studying VP-human protein interactions.
• Destabilizing these interactions can be a strategy for developing therapeutics against Ebolavirus.
• This approach aids in understanding and combating the human immune response antagonism by Zaire ebolavirus VPs.